| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/03/2004 | CN1479872A Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing allosteric regulatory site |
| 03/03/2004 | CN1479744A Crystalline glucosamine sulphate metal salts and its preparation method |
| 03/03/2004 | CN1479736A Benzofuran and benzothiophene derivatives |
| 03/03/2004 | CN1479724A Pyridione derivatives for tretment of atherosclerosis |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II) |
| 03/03/2004 | CN1479625A Herbal pharmaceutical compositions for treating immun logical disorders |
| 03/03/2004 | CN1479612A Pharmaceutical compositions for oral delivery of pharmacologically active agents |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1478541A Design of high effect blood vessel production inhibitor and its application |
| 03/03/2004 | CN1478534A Longgong (scorpion and ground beetle) pain relieving capsule |
| 03/03/2004 | CN1478533A Chinese Medicine for treating cervieal vertebra disease and its preparation method |
| 03/03/2004 | CN1478525A Medicated wine for treating traumatic injury |
| 03/03/2004 | CN1478523A Medicinal particle thremo-therapeutic agent for external use |
| 03/03/2004 | CN1478521A Medicine for relaxing muscles and tendons and activiating colleterals and pain dispelling |
| 03/03/2004 | CN1478507A Medicinal composition for treating fracture |
| 03/03/2004 | CN1478499A Formulation of analgecizing and bone strengthening adhesive plaster and its manufacturing process |
| 03/03/2004 | CN1478492A Medicine for treating arthritis pain and its preparation method |
| 03/03/2004 | CN1478475A Diversine hydrochloride spray and its preparation process |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/03/2004 | CN1140516C Quinoline and quinoxaline compounds which inhibits platelet-derived growth factor on/or p56lck tyrosine kinases |
| 03/03/2004 | CN1140509C Novel vitamin D. analogues |
| 03/03/2004 | CN1140508C Substed 4-biphenyl-4-hydroxybutyric acid derivs, and matrix metalloprotease inhibitors |
| 03/03/2004 | CN1140500C Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 03/03/2004 | CN1140290C Medicine for settnig up bone |
| 03/03/2004 | CN1140284C Chinese-medicinal pill for treating rheumatoid arthritis |
| 03/03/2004 | CN1140274C Medicine for treating osteoporosis and preparing method thereof |
| 03/03/2004 | CN1140270C Calcium antagonist having parathyroid hormone secretion inhibition, preparing method and use thereof |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699903 Hydration of the anhydrous lithium salt with acetonitrile and water; phosphodiesterase inhibitors |
| 03/02/2004 | US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699888 Antiinflammatory |
| 03/02/2004 | US6699881 Thiol compounds, their production and use |
| 03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 03/02/2004 | US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
| 03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks) |
| 03/02/2004 | US6699850 Oral formulation of a combination of nitrogen-containing bisphosphonate or its salt and an isoprenoid compound for inhibiting bone resoprtion in a mammal while counteracting the occurrence of adverse gastrointestinal effect |
| 03/02/2004 | US6699471 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2004016639A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | WO2004016615A1 PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY |
| 02/26/2004 | WO2004016606A1 Pyrazole inhibitors of the transforming growth factor |
| 02/26/2004 | WO2004016597A2 Protein kinase inhibitors and uses thereof |
| 02/26/2004 | WO2004016583A1 Substituted glycine derivatives for use as medicaments |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2004016551A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 02/26/2004 | WO2004016275A1 Separate type medical material |
| 02/26/2004 | WO2004016260A1 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 02/26/2004 | WO2004005328A3 Peptidomimetic compound useful as inhibitor of integrins |
| 02/26/2004 | WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles |
| 02/26/2004 | WO2003106505A9 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 02/26/2004 | WO2003103575A3 Compounds, compositions, and methods |
| 02/26/2004 | WO2003101374A3 Use of new etonogestrel esters |
| 02/26/2004 | WO2003074008A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 02/26/2004 | WO2003073982A3 Anti-interleukin-1 beta analogs |
| 02/26/2004 | WO2003064443A3 New corticosteroids |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003040144A3 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 02/26/2004 | WO2003038058A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 02/26/2004 | WO2003026568A3 Androstanes as androgen receptor modulators |
| 02/26/2004 | WO2003013493A8 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 02/26/2004 | WO2003011892A3 Glp-1 exendin-4 peptide analogs and uses thereof |
| 02/26/2004 | WO2003006425A9 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/26/2004 | WO2002103014A3 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 02/26/2004 | WO2002083058A3 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 02/26/2004 | WO2002069988A3 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 02/26/2004 | WO2002055075A9 Compounds and methods for regulating cell differentiation |
| 02/26/2004 | WO2002055067A3 Fumaric acid derivatives as nf-kappab inhibitors |
| 02/26/2004 | WO2002038775A3 METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE |
| 02/26/2004 | WO2002022112A3 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040039198 Administering to a mammal an aromatic and heteroacromatic substituted imidazole compound to treat diseases: renal disease, wound healing, ucler, ocular disorder, diabetic nephropathy, atherosclerosis, fibrosis, ALzheimer's disease |
| 02/26/2004 | US20040039196 (2-Oxindol-3-ylidenyl) acetic acid derivatives and their use as protein kinase inhibitors |
| 02/26/2004 | US20040039066 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1 |
| 02/26/2004 | US20040039061 Suppress expression and induction of inflammatory cytokines, cell adhesion molecule gene and virus and suppressors for nuclear factor kappa beta (nf-kb) |
| 02/26/2004 | US20040039058 Identifying a mammal having elevated concentrations of tumor necrosis factor- alpha and administering stearidonic acid (18:4, n-3) over a time period |
| 02/26/2004 | US20040039038 Biaromatic compound activators of PPARy-type receptors |
| 02/26/2004 | US20040039029 Thiazolyl urea compounds and methods of uses |
| 02/26/2004 | US20040039015 Estrogen Receptor-beta ligands |
| 02/26/2004 | US20040039006 (2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 02/26/2004 | US20040038991 Imidazolyl-cyclic acetals |
| 02/26/2004 | US20040038979 Novel 6-heteroarylphenanthridines |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 02/26/2004 | US20040038974 Antiarthritic agents |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038963 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 02/26/2004 | US20040038959 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038949 Inhibitors of the enzyme CYP24; useful for treating cell-proliferative disorders and for promoting cell differentiation. |
| 02/26/2004 | US20040038944 Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
| 02/26/2004 | US20040038943 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |